Assertio completes $166M merger with Zydus following bidding war

The deal leaves Lake Forest-based Assertio, which specializes in oncology drugs, as a wholly-owned subsidiary of Zydus Lifesciences.

Jun 19, 2026 - 20:00
 0  2
Assertio completes $166M merger with Zydus following bidding war
The deal leaves Lake Forest-based Assertio, which specializes in oncology drugs, as a wholly-owned subsidiary of Zydus Lifesciences.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow